Navigation Links
Industry Landscape Opens Doors for GeoBargain Polydex Pharmaceuticals
Date:9/27/2013

SKIPPACK, Pa., Sept. 27, 2013 /PRNewswire/ -- GeoInvesting ("We" or "The GeoTeam") has just released a bullish analysis on Polydex Pharmaceuticals Ltd. (OTC Pink: POLXF), a pharmaceutical company that the research firm qualified as a GeoBargain on July 22, 2013 at $0.81 per share. Please see, "Industry Landscape Opens Doors for Pharmaceutical Company Polydex."

GeoBargains are stocks that meet a number of investment criteria that can translate into superior investment returns.  GeoInvesting's approach to identifying potential GeoBargains typically includes:

  • Proprietary screening tools,
  • Extensive analysis of Edgar filings and press releases, and
  • Management interviews.

GeoInvesting's primary focus is to find opportunities in real revenue-generating micro-cap companies with reasonable capital structures.

The GeoTeam's two most recent stocks to be coded as GeoBargains were Gain Capital Holdings and Global Telecom & Tech Inc. Gain Capital Holdings shares are up over 140% since being coded as a GeoBargain on June 6, 2013. We highlighted the company in our article "Double Your Gains with Gain Capital Holdings".

Global Telecom & Tech Inc shares are up over 30% since being coded as a GeoBargain on July 31, 2013.  We highlighted the company in our article "Global Telecom: Near-Term Catalysts Should Close Relative Valuation Gap."

We believe POLXF will capitalize on its own set of catalysts, enabling the company to enter a new phase in its growth cycle and resulting in a potential increase in share price from current levels of around $1.10, or 36% higher than our initial mention of POLXF to our premium members.

To be among the first to receive investment ideas like these, please subscribe to our premium service!

About GeoInvesting, LLC

At GEO, our focus is on providing high quality insights on mid and micro cap equities, both in the China and U.S. spaces. Since our inception, we have come to be known by our GeoBargain selections, a group of stocks with a specific set of criteria that has proven to help them perform better than their peers.  We're confident that you will find GEO to be an excellent source of stock research and analysis.

Terms of Service

GeoInvesting Contacts:
Dan David, Vice President
Ph. 484-991-8426
http://www.geoinvesting.com


'/>"/>
SOURCE GeoInvesting.com
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Aratana Therapeutics to Present at BioCenturys NewsMakers in the Biotech Industry Conference
2. New Research Triangle Company Provides Innovative Global Services To The Pharmaceutical Industry
3. Save Space and Improve Image Quality in Ultrasound Equipment with Industrys Only Highly Integrated Octal Ultrasound Transceiver
4. Health Care Equipment & Supplies: Global Industry Guide
5. Pharmaceutical Market India: A Comprehensive Industry Analysis
6. Research-based Pharmaceutical Industry Calls for Public-Private Sector Engagement to Accelerate Progress Towards the Millennium Development Goals (MDGs) and in Planning New Development Agenda
7. Rubbermaid Commercial Products Debuts Industrys First Disposable Microfiber
8. Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference
9. Mylan Supports Generic Drug Industrys Call on FDA to Uphold Consistent, Proven International Standard for Biosimilar Naming
10. Halozyme Therapeutics To Present At The BioCentury Newsmakers In The Biotech Industry Conference
11. Omeros Chosen to Present at NewsMakers in the Biotech Industry 2013 Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2017)... Calif. , March 27, 2017  Sanderling ... acquired by Ethicon, a division of Johnson & ... System for the treatment of gastro-esophageal reflux disease ... sphincter augmentation (MSA) technology and the procedure is ... centers. Torax Medical was founded by ...
(Date:3/27/2017)... SAN DIEGO and VANCOUVER, British Columbia, March 27, ... SPHS ) (the "Company" or "Sophiris"), a clinical ... treatment of patients with urological diseases, today reported ... and key corporate highlights. Key ... in Clinical Development for Localized Prostate Cancer. During ...
(Date:3/27/2017)... 27, 2017 FinancialBuzz.com News Commentary  ... According to a new report by Arcview Market ... , grew 34 percent to $6.7 billion and can be expected to ... the next five years, from $6.7 billion in 2016, to $22.6 billion ... be able to purchase cannabis without a doctor,s recommendation. Voters in ...
Breaking Medicine Technology:
(Date:3/27/2017)... ... , ... The Case Management Society of America (CMSA) will install six new ... membership has elected their upcoming President-Elect, Secretary, Treasurer and two Directors to serve on ... Advisory position has also been added to the BOD, per an appointment made by ...
(Date:3/27/2017)... ... March 27, 2017 , ... EpiGentek ... to pursue the recent RNA methylation “gold rush” with their established portfolio of ... newfound characteristics of N6-methyladenosine, or m6A , RNA methylation has received a ...
(Date:3/27/2017)... Foothill Ranch, California (PRWEB) , ... March 27, 2017 , ... ... company’s commitment to its customers. First National Capital has added 10 new sales professionals ... to grow its sales positions by 15 additional new hires over the course of ...
(Date:3/27/2017)... RICHEY, Fla. (PRWEB) , ... March 27, 2017 ... ... drug overdose deaths soared 167%,(1) with opioids alone responsible for over 33,000 of ... Kevin McCarty has sponsored Assembly Bill (AB) 1512, which proposes a tax on ...
(Date:3/25/2017)... ... March 25, 2017 , ... Norland at Swissray is pleased to announce the ... subjects. The ELITE DXA has an active scan window, which is more than double ... fit in the scan area could not undergo an accurate total body bone density or ...
Breaking Medicine News(10 mins):